Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for multiple treatment-resistant Kawasaki disease
jRCT1091220201Completed
- Sponsor
- Investigator-initiated Clinical Research(in-house)
- Start
- Dec 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of infliximab in Kawasaki disease (KD), sponsored by Investigator-initiated Clinical Research(in-house). Primary endpoint: Fever resolution within 48 hours. Started Dec 2014; status: completed.
02
Drugs
infliximab
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on jRCT1091220201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220201.